Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology

抗体

山羊抗人类载脂蛋白e

AHP2177

1毫升

多克隆

domestic goat

未共轭

AHP2177

山羊抗人类载脂蛋白e

载脂蛋白e

人类

山羊

血清

多克隆IgG

E

酶联免疫吸附测定

1毫升

1毫升

毫升

GO:0000302, GO:0001540, GO:0001937, GO:0007010, GO:0005543, GO:0006641, GO:0006898, GO:0006916, GO:0006917, GO:0007186, GO:0007263, GO:0007271, GO:0008201, GO:0008219, GO:0010544, GO:0010873, GO:0010875, GO:0016209, GO:0019934, GO:0030425, GO:0030516, GO:0030828, GO:0032488, GO:0032805, GO:0033344, GO:0033700, GO:0034361, GO:0034362, GO:0034363, GO:0034364, GO:0034372, GO:0034375, GO:0034380, GO:0034382, GO:0034384, GO:0034447, GO:0046911, GO:0042627, GO:0042632, GO:0042803, GO:0043025, GO:0043407, GO:0043537, GO:0043691, GO:0045541, GO:0046907, GO:0046982, GO:0048156, GO:0048168, GO:0050728, GO:0070326, GO:0050750, GO:0051000, GO:0051044, GO:0060228

activation of apoptosis, activation of cGMP biosynthetic process, activation of low-density lipoprotein receptor catabolic process, activation of membrane protein ectodomain proteolysis, activation of nitric-oxide synthase activity, anti-inflammatory response, apolipoprotein E receptor binding, apoptosis activator activity, apoptosis inhibitor activity, apoptosis signaling, cGMP-mediated signalling, cholesterol export, commitment to apoptosis, cytoskeletal organization and biogenesis, cytoskeletal regulator activity, cytoskeleton organisation, cytoskeleton organization and biogenesis, dimerization activity, down regulation of blood vessel endothelial cell migration, down regulation of cholesterol biosynthetic process, down regulation of endothelial cell proliferation, down regulation of inflammatory response, down regulation of MAPK activity, downregulation of blood vessel endothelial cell migration, down-regulation of blood vessel endothelial cell migration, downregulation of cholesterol biosynthetic process, down-regulation of cholesterol biosynthetic process, downregulation of endothelial cell proliferation, down-regulation of endothelial cell proliferation, downregulation of inflammatory response, down-regulation of inflammatory response, downregulation of MAPK activity, down-regulation of MAPK activity, G protein coupled receptor protein signaling pathway, G protein coupled receptor protein signalling pathway, GO:0030236, GPCR protein signaling pathway, GPCR protein signalling pathway, G-protein coupled receptor protein signal transduction, G-protein coupled receptor protein signalling pathway, G-protein-coupled receptor protein signaling pathway, G-protein-coupled receptor protein signalling pathway, HDL assembly, HDL clearance, HDL complex, HDL particle, HDL remodeling, HDL2, HDL3, heavy metal chelation, heparan sulfate binding, high-density lipoprotein class complex, IDL complex, IDL formation, IDL particle, induction of apoptosis by p53, inhibition of blood vessel endothelial cell migration, inhibition of cholesterol biosynthetic process, inhibition of endothelial cell proliferation, inhibition of inflammatory response, inhibition of MAPK activity, intermediate-density lipoprotein complex, intermediate-density lipoprotein particle formation, LCAT activator activity, LDL complex, LDL particle, LDL receptor binding, low-density lipoprotein complex, low-density lipoprotein receptor binding, metal chelation, necrosis, negative regulation of cholesterol anabolism, negative regulation of cholesterol biosynthesis, negative regulation of cholesterol formation, negative regulation of cholesterol synthesis, negative regulation of mitogen activated protein kinase activity, negative regulation of mitogen-activated protein kinase activity, neuron cell body, neuronal cell soma, nitric oxide-mediated signal transduction, nitric-oxide synthase activator, NO mediated signal transduction, NO-mediated signal transduction, NOS activator, phospholipid export, positive regulation of cGMP anabolism, positive regulation of cGMP biosynthesis, positive regulation of cGMP formation, positive regulation of cGMP synthesis, positive regulation of low-density lipoprotein particle receptor catabolic process, positive regulation of low-density lipoprotein receptor breakdown, positive regulation of low-density lipoprotein receptor catabolism, positive regulation of low-density lipoprotein receptor degradation, positive regulation of NOS activity, receptor mediated endocytosis, response to active oxygen species, response to AOS, response to reactive oxidative species, response to reactive oxygen intermediate, response to ROI, response to ROS, stimulation of cGMP biosynthetic process, stimulation of low-density lipoprotein receptor catabolic process, stimulation of membrane protein ectodomain proteolysis, stimulation of nitric-oxide synthase activity, triacylglycerol metabolic process, triacylglycerol metabolism, triglyceride metabolism, up regulation of cGMP biosynthetic process, up regulation of low-density lipoprotein receptor catabolic process, up regulation of membrane protein ectodomain proteolysis, up regulation of nitric-oxide synthase activity, upregulation of cGMP biosynthetic process, up-regulation of cGMP biosynthetic process, up-regulation of low-density lipoprotein receptor catabolic process, upregulation of low-density lipoprotein receptor catabolic process, upregulation of membrane protein ectodomain proteolysis, up-regulation of membrane protein ectodomain proteolysis, up-regulation of nitric-oxide synthase activity, upregulation of nitric-oxide synthase activity, very-low-density lipoprotein complex, very-low-density lipoprotein particle receptor binding, VLDL clearance, VLDL complex, VLDL particle, VLDL receptor binding, VLDL remodeling, VLDLR binding

P02649

ApoE基因

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=348

血清

41116161

血清-液体

Primary

加拿大